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Background: Although smoking prevalence in England has declined, one in five adults smoke. Smokers are at
increased risk of a number of diseases, including COPD which affects an estimated 1.5 million people in England
alone. This study aimed to explore issues relating to smoking behaviour and intention to quit that might be used to
inform the development of cessation interventions. Issues explored included knowledge of smoking related disease,
with a particular emphasis on Chronic Obstructive Pulmonary Disease (COPD). Understanding around risk of disease,
including genetic risk was explored, as were features of appropriate and accessible cessation materials and support.
Methods: Semi-structured interviews and focus groups were conducted with a total of 30 individuals of which 17
were smoking cessation clients and 13 were professionals working within health care settings relevant to supporting
smokers to quit. A largely purposive approach was taken to sampling, and data were analysed using the constant
comparative method.
Results: Knowledge of the smoking related disease COPD was limited. Smokers’ concerns around risk of disease were
influenced by their social context and were more focussed on how their smoking might impact on the health of their
family and friends, rather than how it might impact on them as individuals. Participants felt the provision of genetic risk
information may have a limited impact on motivation to quit. Genetic risk was considered to be a difficult concept to
understand, particularly as increased risk does not mean an individual will definitely develop disease. In terms of
cessation approaches, the use of visual media was consistently supported, as was the use of materials that linked
directly with life experiences. Images of children inhaling second hand smoke for example, had a particular impact.
Conclusions: Public health messages around the risks of smoking and approaches to quitting should continue to have
an emphasis on the dangers that an individual’s smoking has on the lives of the people around them. More work also
needs to be done to raise awareness around both the risk of COPD in smokers and the impact this disease has on
quality of life and life expectancy.
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MotivationBackground
Smoking represents a significant public health burden to
individuals, communities and healthcare systems across
the world. The burden of disease from smoking, including
mortality, is most pronounced in low and middle-income
countries but is also a significant problem in developed
countries [1]. Smoking is also a key cause of health in-
equality. In men aged 35–69 years, approximately one-* Correspondence: jb518@le.ac.uk
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able to smoking [2].
The World Health Organization estimate that six mil-
lion people die from smoking related causes each year
[3]. It is estimated that in England two out of every ten
deaths in adults aged 35 and over are as a result of
smoking [4]. Smoking is associated with increased risk
of a number of diseases such as lung, oral pharyngeal
and breast cancer. It is also closely associated with risk
of the respiratory disease Chronic Obstructive Pulmonary
Disease (COPD), where an estimated 73% of deaths are re-
lated to smoking [5].This is an Open Access article distributed under the terms of the Creative
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Symptoms of the disease include breathlessness, cough
and wheezing and people living with condition report
that coping with symptoms and associated exacerba-
tions becomes a ‘way of life’ [7]. It is estimated that in
England alone there are 1.5 million people living with
COPD [8], and a significant number of these will be
current or ex-smokers. However despite this, there is
evidence to suggest that awareness of the disease
among smokers is poor in comparison to diseases like
lung cancer [9]. Although smoking has been described
as the most important cause of COPD [10], genetic
variation also plays a part in an individual’s risk of de-
veloping the disease [11]. As such, smokers with a
greater genetic susceptibility will be at an even higher
risk of developing COPD.
Smoking behaviour is influenced by social context. It
has been reported that in the UK, young girls and chil-
dren of white British origin are at a greater risk of
smoking [12]. Children whose parents smoke are also
at increased risk of smoking in adulthood [13]. Smok-
ing prevalence is also associated with socio-economic
status, and in England approximately one quarter of
people in routine and manual households smoke, com-
pared to 13% of those living in households classified as
being managerial/professional [14].
Those living in deprived communities may face par-
ticular challenges in terms of smoking cessation, as it
has been shown that they are more likely to be in pro-
smoking environments where smoking is normalised
[15,16]. Although cessation attempts do not vary across
socio-economic groups, people in more deprived com-
munities are less successful in their quit attempts [17].
It is possible that smoking in these environments may
facilitate social inclusion within the community and so
may isolate members from positive health promoting
norms [16].
Smoking cessation is an important focus of many
health care systems and in the UK smokers wishing to
quit can access free of charge support from services pro-
vided by the National Health Service (NHS). These
widely promoted services can be accessed through the
smoker’s GP or through self-referral. Smokers are of-
fered support for a period of twelve weeks and this in-
cludes one to one or group support sessions with a stop
smoking adviser. At these sessions clients receive advice
on coping with cravings and avoiding relapse, and are
also offered a breath test that measures the level of car-
bon monoxide present in their body. Clients can also
choose to access a range of nicotine replacement therap-
ies including lozenges or patches, as well as prescribed
medications (bupropion or varenicline). Smokers not
wishing to access this service can receive support for
cessation from their GP.Cessation interventions, including those in the UK,
are commonly underpinned by the transtheoretical
model of behaviour change also known as the ‘stages of
change’ model [18]. The model suggests that chronic
behaviours can be categorised into one of five stages:
pre-contemplation, contemplation, preparation, action
and maintenance [19]. In terms of smoking cessation
this means that once an individual has made the deci-
sion to stop smoking, they move from the contempla-
tion and preparation stages into action, which may
include accessing a smoking cessation service. By pro-
viding nicotine replacement therapy, the service aims
to assist the individual through the action stage and
into long term maintenance.
Large scale media campaigns also form part of gov-
ernment funded tobacco control interventions in the
UK. Such campaigns have been shown to have a positive
effect on smoking in adults, both in terms of reducing
smoking prevalence and overall cigarette consumption
[20,21]. A study of media campaigns in England re-
ported that messages relayed in these campaigns tend
to focus on the negative consequences of smoking [22].
However, a study of the emotive content of campaigns
found that compared to negatively emotive messages,
positively emotive messages had a bigger impact on the
number of smokers calling a cessation telephone ‘quit
line’ [23].
However, despite having access to a range of smoking
cessation interventions, people continue to smoke. Rea-
sons for this might include that smokers tend to down-
play the risks smoking poses to their health [24,25] and
at the same time overly emphasise perceived benefits
such as stress relief [25]. Smokers may also generally
underestimate their own risk compared to that of the
average smoker [26,27].
The public health challenge is to develop and deliver
smoking related interventions that are effective and
take into account socially contextualised motivators
and barriers to successful cessation. The aim of this
study was to explore what both smokers and profes-
sionals working with smokers thought were the key fac-
tors that influenced the decision to stop smoking. This
included understanding of smoking related disease,
with a particular emphasis on COPD. Understanding of
risk and how genetic risk of a smoking disease such as
COPD would impact on smoking behaviour were also
explored, as were views on what works in terms of
smoking cessation initiatives.
Methods
The study design and conduct were informed by the
RATS guidelines [28]. A qualitative approach, using
focus groups and semi-structured interviews was used to
allow participants to express their feelings and experiences
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tion, appropriate ethical and organisational approval was
obtained for research done in the UK NHS system. A lit-
erature review was conducted and examples of smoking
cessation materials available through the NHS, as online
resources or as smartphone applications, were collected
and reviewed in order that they could be used as examples
when discussing aids with participants. To gain a better
understanding of both smoking and smoking cessation, a
member of the study team (BM) also shadowed a desig-
nated core worker from a NHS smoking cessation service.
This involved observing a number of smoking cessation
appointments and talking to workers about the content
and structure of a typical cessation programme.
Recruitment
In order to answer our research question, a mixed sam-
pling approach was adopted. In terms of client partici-
pants, smoking cessation clinic venues were selected
purposively according to their client profile and local
demographics. Three venues were identified by the local
NHS smoking cessation service. The first was in an area
of high deprivation with a predominantly White British
population and an older age profile than that of the city
as a whole. The second was in an area with a similar age
profile but with low levels of deprivation and an ethnic-
ally diverse population. The final site was in an area of
ethnic diversity, but with high levels of deprivation and a
younger age profile than the city as a whole.
Once the clinic venues were selected, clients were eli-
gible for inclusion if they were current or ex-smokers
and aged 18 years or over. Initially a smoking cessation
advisor in the three clinic venues introduced the study
to eligible clients and then those interested were asked
to provide their contact details to the study team. It was
the intention that potential participants would be se-
lected for inclusion according their characteristics, in-
cluding age, gender and ethnicity. However, only five
cessation clients responded using this approach. As a re-
sult, an ethics amendment was sought to allow the study
researcher (BM) to recruit directly from clinic venues.
Clients were then approached largely on an opportunis-
tic basis although the researcher actively attempted to
ensure that both male and female clients were recruited.
Overall 17 clients agreed to be interviewed and five
agreed to participate in a group discussion. Of these 12
were female and five were male.
In addition to client participants, 13 professional par-
ticipants were also recruited. Potential professional par-
ticipants were identified purposively according to their
role and included those working with NHS smoking ces-
sation services or in relevant area of health service deliv-
ery. General Practitioners and Practice Nurses were
recruited to take part in a focus group discussion or aninterview through a local primary care training event.
One additional GP and a Practice Nurse with a specific
interest in COPD were identified through a local COPD
focussed conference. A hospital based Consultant working
in the area of respiratory care and two senior pharmacists
with specific interests in respiratory illness were also iden-
tified through this event. Members of a local COPD
strategy group also participated in a group discussion.
Data collection
Data were collected through semi-structured interviews
and focus groups. Four focus groups were conducted in
total, two with professionals and two with smoking ces-
sation clients. In addition, 16 one to one interviews were
conducted with four professional participants and 12 cli-
ent participants. Although no cash payment was pro-
vided to participants, client participants were offered a
£20 high street gift voucher as a thank you for taking
part in the study. Data were collected between Novem-
ber 2012 and June 2013.
All interviews were conducted by BM who does not
have a clinical, public health or smoking cessation back-
ground. Focus groups and group discussions were con-
ducted primarily by BM and moderated by JB and/or a
member of academic staff employed by the University of
Leicester. All interviews and group discussions were
audio-recorded with the agreement of the participant(s)
and all participants gave written informed consent prior
to data collection.
A topic guide was used to facilitate data generation
and participants were asked to share:
 Views on smoking and smoking cessation, including
what influences decision to quit
 Understanding of smoking related disease, with a
particular emphasis on Chronic Obstructive
Pulmonary Disease (COPD)
 Views and experiences (both positive and negative)
of different smoking cessation interventions,
including views on the suitability and usefulness of
different types of media and the use of novel
approaches.
Data analysis
All interviews were audio-recorded and transcribed verba-
tim. Analysis was iterative and informed by the constant
comparative method [29]. Preliminary open codes were
generated from each focus groups and then emerging
ideas were tested, developed and refined throughout the
subsequent focus groups and one to one interviews. Pri-
mary analysis was done by BM and shared and discussed
with JB to ensure appropriate reporting and interpretation.
Any disagreement or requirement for clarification was re-
solved by JB and BM returning to the transcribed data
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sion was evidenced by the data collected.Results
Analysis of the data identified several key themes com-
mon across smoking cessation clients and professionals.
Relationships with children and the wider family and
also finances acted as key motivators in deciding to
change smoking behaviour. Risk to themselves as a
smoker had little impact on decision to change behav-
iour, but the impact of their behaviour on the risk of
causing illness in others held much more weight. Clients
also had limited knowledge or understanding of COPD,
and what knowledge they did have tended to be through
the lived experience of friends or family members who
had been diagnosed with the disease.The impact smoking has on others as a motivating factor
to quit
Client participants consistently reported that relation-
ships with either their children, or with other family
members, were primary drivers in their decision to stop
smoking or reduce the amount they smoked. This was
consistent with the views of professional participants.
Those who were ex-smokers felt this had influenced
their own smoking behaviour and could also be used as
a lever to promote cessation in others:
Agnes: …there was the advert with children involved
in smoke and that did have an impact on me. I didn’t
smoke around children… no, that did have an impact.
Harriet: I’d concur with that. It’s what hit home with
me to stop smoking.
Agnes: Yeah … that really hit home powerfully. But
yeah it was the connection with my own children.
(Agnes and Harriet, professionals who are ex-smokers
working in the field of smoking cessation)
When asked about the harm that smoking caused, the
consensus was that smokers understand and accepted
that they are harming their own bodies. They were, how-
ever, far more concerned that their actions could be
harming others, particularly children:
“More than what you would on your health reasons.
Cos everybody’s not really, apart from the health
fanatics, nobody’s actually bothered about their health
are we?” (Adam, Client participant).
and“I think it’s as well I don’t mind damaging my own
body, I do that quite successfully actually, but yeah I
think it’s the fact that (it has) an impact on your
children I think always to me has a great, you know,
as a mother it has a greater impact I think” (Agnes,
Professional participant and ex-smoker).
This was directly counterpointed by smokers without
children who stated that messages around the impact of
smoking on children had no meaning to them:
“See I don’t have children so it had no impact on me
what so ever. I saw it, but it didn’t really mean
anything to me, because I don’t have children so again
I think it’s because people relate it to their own lives
don’t they?” (Allan, professional participant and ex-
smoker).
As well as being fearful of exposing children and family
members to harm through second hand smoke, partici-
pants were also aware that smoking impacted negatively
upon their ability to participate in family life:
“Especially now you’ve got a grandson you see it more
like missing out on like his walking or talking or you
might miss that first word because you’ve nipped out
for a cigarette”. (Belinda, client participant)
Smoking as a financial burden
The financial burden associated with smoking was for
some an additional factor to health concerns that trig-
gered a desire to quit, whilst for others health had very
little bearing and the decision was a purely financial one:
“Money. Both money and health reasons. Cos I was
smoking quite a lot. I was on about fifty to sixty a day”
(Felix, client participant)
and:
“…some people pack up for health reasons but
whatever reasons to pack up for, I’m trying to save
money I’m smoking for the bedroom tax, so… if you
pack up smoking you can get yourself a nice car or pay
for your bedroom tax”. (Adam, client participant)
Professionals working with smokers also raised finan-
cial costs, both in the short and long term, as reasons
why their patients or clients had made the decision to
stop smoking. One professional participant (a General
Practitioner) reported an incident where he had success-
fully and perhaps almost unintentionally acted as a dir-
ect trigger for a patient to stop smoking. This has been
achieved by linking an important health message to that
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tient’s wishes to have a good retirement:
“…financial issues help. I know that I told, someone
came to me for a medical 25 years ago for a pension,
life insurance and I said ‘oh’ I said ‘you must love your
wife very much.’ He said ‘why do you say that?’ I said
‘well you’re smoking 20 a day you’re not going to be
around to pick it up’, So I didn’t see him for about
20 years, forget why he came in..So he said ‘not since
the day I came in for my medical, I stopped that day’.
Interviewer: Successful point of contact.
“It was relevant. I’m saving for my retirement and I’m
not going to be around to pick it up. What the hells
the bloody point?” (Borris, professional participant)
The impact of health messages and advice
There was an agreement between healthcare professionals
and smoking cessation service clients that smokers were
unlikely to take notice or would be sceptical of the merits
of health care advice around the risks of smoking unless
that advice directly affected their life or the lives of people
they knew and cared for.
Resistance to health advice in the form of media cam-
paigns again was associated with how the message im-
pacted upon the clients lived experience and on their
ability to link the information presented to their own life.
This was associated with the ability to link with other peo-
ple’s real–life experiences and successes in giving up
smoking, although these also had to be credible and ‘real’.
The use of actors, for example, to relay even true stories
was thought to have limited impact as it was still ‘not real’:
“Being cynical I could say well that’s an actor, even
though I know it’s real. But like I think no that could
be an actor. That’s not a real person, so you’re talking
rubbish sort of thing”. (Deirdre, client participant)
For some the resistance to health information was as-
sociated to feeling bombarded with often very negative
images related to smoking and other lifestyle related is-
sues such as obesity. These had lost meaning to these
clients who actively ignored them:
“You just think oh well another one. That’s what it’s
getting like. Every time you turn the telly on there’s
something about health things, either smoking or
losing weight….” (Adam, client participant).
Understanding of smoking related disease
In terms of understanding of disease, discussion of smok-
ing related disease tended to be orientated around cancerand not around other important diseases like COPD. The
client participants generally had a poor understanding of
this specific disease. Again knowledge was associated with
experience, and those who had some basic knowledge
about COPD predominantly already had either emphy-
sema or chronic bronchitis, or knew someone with these
diseases:
“I’ve seen people with COPD, so I know how poorly
they can be. It does make you worry, it really does”.
(Grace, client participant)
In addition to broad health messages around smoking
cessation, both clients and professionals were asked their
views on whether the provision of information to smokers
that included personalised genetic risk of a smoking dis-
ease, such as COPD, would impact on smoking behaviour.
Again there was resistance to this from clients in that it
was thought to be difficult to understand, particularly in
understanding that increased risk of a disease does not
mean a person will definitely go on to develop that dis-
ease, or that any change in lifestyle would guarantee
avoiding it. This was further compounded by having
friends or family who despite being non-smokers had
still gone on to develop diseases often associated with
smoking:
Francine: There’s always going to be things like that with
genetics. Some people will think yeah genetic make-up
could be a high risk of having cancer, this, that and the
other. Change your lifestyle you might not get it, but
who’s to say you could get it or you couldn’t?
Edmond: … they always say cancer is a lot to do with
smoking. I’ve known people that don’t smoke, never
have done in their life, never been in a smoke
environment, but died of lung cancer. Arguments over
everything. Especially where genetics is concerned. I do
admit it’s good on some things like one illness me
daughter’s got that is a genetic thing, but on other
things when do you say that it is genetic or not? And I
don’t think knowing would help”. (Edmond and
Francine, client participants)
The delivery of cessation messages
Participants were also asked about their views and experi-
ences of smoking cessation interventions, both in terms of
the form of media used and in the key messages that were
relayed. Consistently, visual media was seen as having
both the biggest impact and being the most accessible ap-
proach to relaying information:
“I think, I know a lot of our patients, they’re not
readers, and so leaflets isn’t so valuable but a visual
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helpful”. (Gina. Professional participant).
The use of visual media, in particular new media tech-
nologies such as interactive mobile applications, online
videos and games were seen as vehicles which provide
ways to engage smokers around future health risks. The
participants felt that such approaches may be particu-
larly helpful in preventing initiation of smoking in young
people, but also felt that they may have less impact on
older smokers:
“Apps are OK for younger generations and
internets are OK for the younger generation. Older
generation they have no idea how to go in. I tell
patients to go and look at the NHS Choices site, they
don’t. They always complain they couldn’t get
through to it. So these things will take maybe
another generation for them to use it well”. (Larry.
Professional participant)
And
“There’s this thing, isn’t there, whereby they take your
photo as you are now and then they show you a
picture of you in, I don’t know, 15/20 years’ time if you
carry on smoking and that’s, I think especially for
young girls especially, that would be quite an eye
opener to say, “Look, you’re going to have these lines
and this sagginess as well as smelling awful.” I think
that’s a really good… that part of it was really good
but obviously that was since I’ve stopped smoking but
visually it’s quite powerful. This is what will happen
you know and I think using new technologies is
probably… how you do it I don’t know but if you’re
using new technologies like that it’s quite effective,
especially with younger people.” (Katie. Client
participant)
As discussed earlier, the potential physical harm to
children and loved ones was a powerful influence on
some smokers’ decision to quit. In terms of cessation
materials and the impact of these, the emotional harm
that smoking has on children was also seen as important
lever:
“And the one that they had not long ago was children
or a child would come up on the TV and he would
say, “Dad, I want you to live” and it was so emotional.
You’d watch it and at the end he’d say, “Please quit




The findings of this study suggest that tackling the health
burden of smoking is not merely a matter of solving a
physical addiction and that smoking cessation approaches
and related information needs to take into account an in-
dividual’s lived experience and their social context. They
also suggest that public health messages that rely on indi-
vidual health outcomes may have less impact than those
that illustrate the effect of an individual’s behaviour on
others, particularly children and family members. Further-
more, in terms of knowledge around the health implica-
tions of smoking, there appears to be a general lack of
understanding around the full range of smoking related
diseases. Cancer seemed to be well understood but COPD,
which is highly associated with smoking, was not. Also
this study suggests that risk as a general concept may be
difficult for some smokers to understand or conceptualise.
This may be compounded by having friends or family who
despite being non-smokers, have developed smoking re-
lated disease.
How this study fits
This study found that risk of smoking related disease
tended to be considered in terms of how smoking impacts
on risk of ill-health in others, particularly children and
family members. Impact on children’s health in particular
has been reported as being a key motivator in either the
decision to quit smoking or to have a smoke free home
[30]. However, a study of smokers in a similar disadvan-
taged inner city area found that knowledge was variable
around the dangers of second hand smoke and that the
impact of smoking on the smell and décor of the house
were bigger motivators than the health consequences for
their children [31]. A systematic review of interventions
targeted at parental cessation found that interventions
were only effective for parents of children over 4 years of
age and not for younger children and babies [32]. Why
smokers do not change their behaviour to minimise their
risk and also the risk for those around them may be asso-
ciated with levels of social support. A smoker who is moti-
vated to quit or to limit exposure of children to second
hand smoke may still find their efforts negated by a part-
ner who is unwilling to change their behaviour [30].
In this study, personal health outcomes and risk of de-
veloping disease tended be discussed in relation to luck.
This was rooted in experience of having family or friends
who did not smoke but still went on to develop diseases
commonly associated with smoking, and vice versa. This
could reflect a general underestimation of personal risk in
smokers [26,27,33] or a degree of misunderstanding
around key risk factors for disease [26]. Weinstein and
colleagues, in a large scale survey of smokers and non-
smokers, reported that smokers tend to underestimate
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smoker’. They also found that smokers who did not intend
to quit were significantly more likely to report that a per-
son’s genetics were primarily responsible for lung cancer
development [26].
In addition to seeing their risk of developing smoking
related disease as being influenced by luck, the client
participants were more likely to talk about health risks
associated with smoking in relation to cancer. Know-
ledge of COPD, which is also highly associated with
smoking, was very limited. This lack of knowledge has
been reported elsewhere in a qualitative study of patients
at risk of COPD, who saw lung cancer as the primary
risk to their health [9]. Again in the current study, al-
though overall knowledge was poor, it was better among
those that had experience of the disease either personally
or through friends and family.
Participants were asked to consider how the provision
of information on genetic risk of a condition such as
COPD might impact on motivation to stop smoking. This
was raised with participants as there are technologies
available that can demonstrate how risk of COPD is influ-
enced by genetic variation, and how this risk changes ac-
cording to smoking status. The ‘Risky Gene Machine’ for
example is a web-based application that shows how
COPD risk is influenced by both genetic variation and
smoking status [34], and it is possible that visual media
such as this could be used with smokers as part of a cessa-
tion programme.
The evidence around the impact of providing genetic
risk information on health related behaviour is though
limited [35]. Although the provision of such information
does not seem to promote a fatalistic approach to health
and related behaviours [36], how it impacts on actual be-
haviour is unclear. Marteau and colleagues in a systematic
review concluded that providing DNA based disease risk
estimates may have an impact on intention to change be-
haviour, but does not lead to actual behaviour change in
the short or long term [35]. Why is unclear, although the
participants in our study felt that this would be a complex
message to relay and understand. Also, this complexity ap-
peared to be linked with fact that the risk information pro-
vided may not be absolute – i.e. an increased risk does not
mean that an individual would definitely develop disease,
and quitting smoking may not mean an individual would
definitely not develop disease.
In terms of communicating cessation messages, partici-
pants in this study felt that visual media may be particu-
larly effective in delivering key cessation messages. Again,
participants tended to refer to media campaigns that
highlighted the impact smoking had on others, particu-
larly children. Campaigns that included ‘real’ people also
held more weight. Such approaches have been found to
have a positive impact. In the United States a large scalesmoking cessation campaign called ‘Tips from former
smokers’ uses very visual emotive advertisements and
real-life stories. The people involved have been affected by
smoking, some have never smoked but have illnesses
caused or triggered by smoking, whilst others are ex-
smokers suffering from diseases such as throat cancer or
COPD. In terms of impact, the programme reached a
large proportion of smokers (just under 80% recalled see-
ing at least one of the Tips advertisements) and was asso-
ciated with an estimated 1.64 million quit attempts, an
absolute increase of 3.7% [37].
Strengths and weaknesses of the study
A particular strength of this study was the diversity of
participants in that both the professional and client per-
spective was sought and also in the overall number of
smokers that contributed to the study. In addition, the
study recruited largely client participants through clinics
orientated around more deprived communities and as
such may reflect the views and experiences of partici-
pants from communities where smoking behaviours are
more normalised and so more entrenched.
The main limitation of this study is that with the excep-
tion of a small number of professionals who were also
smokers, we accessed current and ex-smokers through a
NHS smoking cessation service. This means that the find-
ings presented may not represent the views and experi-
ences of people who quit without support from such a
service, or smokers with no agenda to quit. In addition, it
proved more difficult than anticipated to recruit smoking
cessation clients. As a result, it was not possible to take a
truly purposive sampling approach with this group. More
women than men participated, and we were unable to re-
cruit participants from a range of ethnic backgrounds.
Conclusion
Although overall smoking prevalence in England has de-
clined in recent years, it continues to vary according to
socio-economic status. This may be because cessation
approaches are struggling to successfully engage these
smokers at the pre-contemplation stage. Based on the
findings of this study, those in lower socio-economic
groups might place greater value on the impact that
their smoking has on other people rather than them-
selves. This group might also benefit from a greater un-
derstanding of the health impacts of smoking outside of
those associated with risk of cancer. More work needs to
be done on risk communication strategies, as smokers
may struggle to both conceptualise risk and underesti-
mate their own risk of smoking related disease.
Finally taking into account the potential importance of
social context and networks, the development and delivery
of smoking cessation interventions may also benefit
from increased input from smokers and users of smoking
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http://www.biomedcentral.com/1471-2458/15/4cessation services. On a community level, involved indi-
viduals become carriers of new knowledge and can have a
positive impact within their community by introducing
this to their friends and relatives. On a wider level, greater
involvement could help ensure that cessation approaches
have a focus that reflects key motivating factors that are
relevant to the target group.
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